1. Home
  2. ZTO vs UTHR Comparison

ZTO vs UTHR Comparison

Compare ZTO & UTHR Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.

Logo ZTO Express (Cayman) Inc. each representing one ordinary share.

ZTO

ZTO Express (Cayman) Inc. each representing one ordinary share.

HOLD

Current Price

$21.68

Market Cap

15.2B

ML Signal

HOLD

Logo United Therapeutics Corporation

UTHR

United Therapeutics Corporation

HOLD

Current Price

$489.62

Market Cap

20.3B

Sector

Health Care

ML Signal

HOLD

Company Overview

Basic Information
Metric
ZTO
UTHR
Founded
2002
1996
Country
China
United States
Employees
N/A
N/A
Industry
Advertising
Biotechnology: Pharmaceutical Preparations
Sector
Consumer Discretionary
Health Care
Exchange
Nasdaq
Nasdaq
Market Cap
15.2B
20.3B
IPO Year
2016
1999

Fundamental Metrics

Financial Performance
Metric
ZTO
UTHR
Price
$21.68
$489.62
Analyst Decision
Strong Buy
Buy
Analyst Count
4
12
Target Price
$21.90
$495.08
AVG Volume (30 Days)
1.5M
424.3K
Earning Date
11-19-2025
10-29-2025
Dividend Yield
2.77%
N/A
EPS Growth
N/A
16.08
EPS
1.16
26.38
Revenue
$6,673,175,085.00
$3,128,400,000.00
Revenue This Year
$12.15
$13.64
Revenue Next Year
$11.36
$5.78
P/E Ratio
$18.69
$18.55
Revenue Growth
13.17
13.50
52 Week Low
$16.34
$266.98
52 Week High
$22.01
$492.62

Technical Indicators

Market Signals
Indicator
ZTO
UTHR
Relative Strength Index (RSI) 77.13 68.10
Support Level $20.31 $470.13
Resistance Level $20.90 $492.62
Average True Range (ATR) 0.42 10.72
MACD 0.19 -0.53
Stochastic Oscillator 93.69 89.55

Price Performance

Historical Comparison
ZTO
UTHR

About ZTO ZTO Express (Cayman) Inc. each representing one ordinary share.

ZTO Express is China's largest express delivery company by parcel volume, with a volume share of 19.4% in 2024. It operates a network partner model where it provides line-haul transportation and sorting services, while its local network partners provide first-mile pickup and last-mile delivery services under the ZTO brand name. Headquartered in Shanghai, the company was founded in 2002 by Meisong Lai, who remains chair, CEO, and its major shareholder with 78% voting rights as of March 31, 2025. ZTO's strategic shareholder is leading China e-commerce company Alibaba Group with around an 8.9% interest.

About UTHR United Therapeutics Corporation

United Therapeutics Corp specializes in drug development for pulmonary arterial hypertension (PAH), a rare and progressive disease marked by abnormally high blood pressure in the arteries of the lungs. The company's therapies for PAH largely focus on the prostacyclin pathway, and many of its treatments are based on the same molecule, treprostinil. The company markets and sells the following commercial therapies in the United States to treat PAH: Tyvaso DPI (treprostinil) Inhalation Powder, Remodulin Injection, Orenitram (treprostinil) Extended-Release Tablets, Adcirca (tadalafil) Tablets, and Unituxin. In addition, it is developing a pipeline of projects that includes new indications and delivery devices for existing products and new products to treat PAH and other conditions.

Share on Social Networks: